Joseph A Sparano

Trials

Studies that name Joseph A Sparano as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:37 UTC. Open this list on ClinicalTrials.gov

• N/A
  NCT06786585 · Extended Clinical Follow up and Biospecimen Collection for Patients Enrolled in TAILORx and RxPONDER: A Companion Protocol

  Eastern Cooperative Oncology Group · not yet recruiting · Breast Cancer · principal investigator
• Ph1
  NCT01351909 · Cyclophosphamide and Veliparib in Treating Patients With Locally Advanced or Metastatic Breast Cancer

  National Cancer Institute (NCI) · active not recruiting · Locally Advanced Unresectable Breast Carcinoma, Metastatic Breast Carcinoma, Recurrent Breast Carcinoma · principal investigator
• N/A
  NCT00897299 · Identifying Genes That Predict Recurrence in Women With Breast Cancer Treated With Chemotherapy

  Eastern Cooperative Oncology Group · completed · Breast Cancer, Estrogen Receptor, Her-2 · study chair
• Ph2
  NCT00324415 · Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer

  AIDS Malignancy Consortium · completed · Anal Cancer · study chair
• Ph2
  NCT00316888 · Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer

  ECOG-ACRIN Cancer Research Group · completed · Anal Cancer · study chair
• Ph3
  NCT00310180 · Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)

  National Cancer Institute (NCI) · active not recruiting · Breast Adenocarcinoma, Hormone Receptor Positive, Stage IA Breast Cancer AJCC v7 · principal investigator
• Ph3
  NCT00003010 · Marimastat or No Further Therapy in Treating Women With Metastatic Breast Cancer That Is Responding or Stable Following Chemotherapy

  Eastern Cooperative Oncology Group · completed · Breast Cancer · study chair
• Ph3
  NCT00004125 · Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes

  Eastern Cooperative Oncology Group · completed · Breast Cancer · study chair

Grants

NIH projects from RePORTER, fetched 2026-11-12 11:37 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

• Clinical Protocol & Data Management (CPDM)
  P30CA013330 · NCI · ALBERT EINSTEIN COLLEGE OF MEDICINE · fiscal years 2007 to 2021 · $175,117 awarded in 2021
  Grant number is on one of their registry trials
• MINORITY-BASED COMMUNITY ONCOLOGY PROGRAM
  UG1CA189859 · NCI · MONTEFIORE MEDICAL CENTER (BRONX, NY) · fiscal years 2014 to 2019 · $753,649 awarded in 2019
  Same name and institution; not confirmed by an ID
• EASTERN COOPERATIVE ONCOLOGY GROUP
  U10CA014958 · NCI · ALBERT EINSTEIN COLLEGE OF MEDICINE · fiscal years 2002 to 2013 · $144,167 awarded in 2013
  Same name and institution; not confirmed by an ID
• Early Therapeutics Development with Phase II Emphasis
  N01CM62204- · NCI · MONTEFIORE MEDICAL CENTER (BRONX, NY) · fiscal years 2007 to 2011 · $472,963 awarded in 2011
  Grant number is on one of their registry trials
• EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS-261622004
  N01CM622004 · NCI · MONTEFIORE MEDICAL CENTER /INC · fiscal years 2006
  Same name and institution; not confirmed by an ID
• AIDS MALIGNANCY CONSORTIUM
  U01CA083038 · NCI · MONTEFIORE MEDICAL CENTER (BRONX, NY) · fiscal years 1999 to 2005 · $86,250 awarded in 2005
  Same name and institution; not confirmed by an ID

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• AMC OPERATIONS CENTER
  U01CA070019 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Jeannette Y. Lee · fiscal years 1995 to 2005
  Named on NCT00324415
• ECOG Statistical Office
  U10CA023318 · NCI · DANA-FARBER CANCER INST · PI ROBERT J GRAY · fiscal years 1985 to 2013
  Named on NCT00316888
• ECOG-ACRIN Network Group Operations Center
  U10CA180820 · NCI · ECOG-ACRIN MEDICAL RESEARCH FOUNDATION · PI Peter J ODwyer, MITCHELL D. SCHNALL · fiscal years 2014 to 2026
  Named on NCT00310180
• Eastern Cooperative Oncology Group Operations Office
  U10CA021115 · NCI · FRONTIER SCI & TECHNOLOGY RSCH FDN, INC · PI ROBERT L COMIS · fiscal years 1985 to 2013
  Named on NCT00310180